UNSPSC 51183622: Insulin aspart/Insulin aspart protamine

Insulin aspart protamine and insulin aspart is a combination of a fast-acting insulin and an intermediate-acting type of human insulin.

UNSPSC 51183622 Insulin aspart/Insulin aspart protamine is a Commodity code that captures state and local procurement of specific insulin formulations for healthcare delivery, yet the recent opportunities block shows minimal relevant activity. Of the 14 records posted between April and October 2026, only two involve pharmaceutical procurement: the Dane County RFP for comprehensive pharmaceutical services to a long-term care facility (Badger Prairie Health Care Center), and the West Texas Centers RFP for prescription and pharmacy services across 35 service sites serving over 7,000 individuals. Neither solicitation specifically names insulin aspart or aspart protamine formulations; both are broad pharmacy services RFPs encompassing general medication procurement, dispensing, inventory management, and delivery across mixed therapeutic categories. The remaining records address unrelated procurement activity—EMS drug-dosage calculation software (Collier County), naloxone distribution systems and safe drug deactivation (Seminole County and Washington County), a pharmacy benefits program network (District of Columbia), a group purchasing organization (San Mateo County), and pharmaceutical supplies for emergency medical services (Tucson Fire Department). Three records are events or administrative notices rather than active solicitations.

The code shows limited identifiable state and local contracting volume under this specific insulin formulation in the current opportunity stream. Issuing bodies in the pharmaceutical procurement records include Dane County (Wisconsin), West Texas Centers for Mental Health and Mental Retardation (Texas), and San Mateo County (California), representing county governments and regional health service organizations rather than concentrated activity. Geographic spread across these records spans Wisconsin, Texas, California, and Florida. The Dane County RFP (2026RFP061PR, due October 22, 2026) requires comprehensive drug distribution with daily delivery, medication dispensing, barcode scanning, and secure web portal communication for a five-year term beginning January 1, 2027; the contract is structured at $125,000 in annual county funding with local-vendor preference (five bonus points for Dane County vendors, two points for adjacent counties). The West Texas Centers RFP (RX1001, due August 21, 2026) encompasses medication purchasing, dispensing in multiple formats including injectable, delivery across 23 counties, and pharmacist consultation, with compensation using tiered markup on invoice acquisition cost plus per-prescription and patient-assistance-program fees. No recent solicitation explicitly isolates insulin aspart or aspart protamine as a line-item procurement, and the code does not clearly map to active state and local contracting activity in the record set provided.